![Metoprolol better than atenolol in therapy of cardiac failure! Role of peripheral NPY!? | Bengtablad's Blog Metoprolol better than atenolol in therapy of cardiac failure! Role of peripheral NPY!? | Bengtablad's Blog](https://bengtablad.files.wordpress.com/2012/01/table_1-01.png)
Metoprolol better than atenolol in therapy of cardiac failure! Role of peripheral NPY!? | Bengtablad's Blog
![Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers](https://ijp-online.com/articles/2014/46/5/images/Indian%20J%20Pharmacol_2014_46_5_485_140577_t4.jpg)
Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers
![Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio](https://scielo.isciii.es/img/revistas/pharmacy/v7n4/205-212_03.gif)
Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio
Switching to once-daily evidence-based [beta]-blockers in patients with systolic heart failure or left ventricular dysfunction after myocardial infarction - Document - Gale OneFile: Health and Medicine
![Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure - ScienceDirect Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109701014711-gr1.gif)
Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure - ScienceDirect
![Table 5 from Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). | Semantic Scholar Table 5 from Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/756f1a156300486fff78e90803b94ee14c5b9b76/7-Table5-1.png)
Table 5 from Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). | Semantic Scholar
![Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio](https://scielo.isciii.es/img/revistas/pharmacy/v7n4/205-212_04.gif)
Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio
![Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial | Semantic Scholar Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/91fe0292f4ac6e62b247a156b06280b9a441603d/5-Table3-1.png)